Capstone Investment Advisors, LLC Iovance Biotherapeutics, Inc. Transaction History

Capstone Investment Advisors, LLC

  • $30.4 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$7.78 - $14.19 $131,785 - $240,364
16,939 New
16,939 $135,000
Q4 2023

Feb 12, 2024
SELL
$3.3 - $8.89 $25,482 - $68,648
-7,722 Reduced 27.09%
20,785 $168,000
Q3 2023

Nov 13, 2023
BUY
$4.44 - $8.79 $58,337 - $115,491
13,139 Added 85.5%
28,507 $129,000
Q2 2023

Aug 10, 2023
BUY
$5.36 - $9.06 $82,372 - $139,234
15,368 New
15,368 $108,000

Others Institutions Holding IOVA

# of Institutions
314
Shares Held
241M
Call Options Held
3.77M
Put Options Held
1.7M
View Full List

About IOVANCE BIOTHERAPEUTICS, INC.

IOVA Quotes by TradingView
  • Ticker IOVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 157,800,992
  • Market Cap $1.36B
  • Description
  • Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...
More about IOVA
Track This Portfolio

Track Capstone Investment Advisors, LLC Portfolio

Follow Capstone Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capstone Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capstone Investment Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email